NalaGenetics x Bio-Rad Webinar Empowering Preventive Healthcare: Advancing Pharmacogenomics with Bio-Rad and NalaGenetics qPCR Solutions
In this webinar, we will present the outcomes of a study conducted across the primary ethnic groups in Singapore and Indonesia, utilizing the Bio-Rad CFX96 Touch™ Real-Time PCR System registered for IVD use with the Nala PGx Core® assay, showcasing robust and precise genotyping results.
The clinical utility of pharmacogenomics (PGx) is growing due to the discovery that 70% of adverse drug reactions (ADRs) are linked to genetics. Screening for specific pharmacogene variants, which influence drug metabolism and biodistribution, can customize treatments and minimize ADR risks. To support such efforts, the Nala PGx Core® provides a quantitative PCR-based multi-gene panel comprising 18 variants and 2 CYP2D6 copy number variants (CNV) markers, spanning 4 key pharmacogenes: CYP2C9, CYP2C19, CYP2D6, and SLCO1B1.
In this webinar, we will present the outcomes of a study conducted across the primary ethnic groups in Singapore and Indonesia, utilizing the Bio-Rad CFX96 Touch™ Real-Time PCR System registered for IVD use with the Nala PGx Core® assay, showcasing robust and precise genotyping results. Additionally, with the introduction of the next generation of real-time PCR systems from Bio-Rad's CFX Opus product line, we also performed validation of the new qPCR platform's potential to accommodate the Nala PGx Core® assay panel by comparing results obtained from both the CFX Opus 96 Real-Time PCR (RUO) and the CFX Opus 96 Dx (IVD) Real-Time PCR Systems.
About the speaker:
Caroline Mahendra, Genetics Lead, NalaGenetics
Caroline Mahendra is an accomplished professional with a Master's in Engineering Management from Duke University and a Bachelor's in Chemical Biology from UC Berkeley. She was a research scientist at UC San Francisco with publications in Nature and Cell journals. With a strong foundation in both science and management, she currently leads the Genetics Department at NalaGenetics, focusing on developing and producing IVD medical devices and laboratory workflows for molecular diagnostics. Caroline's role showcases her expertise in bridging her educational background with practical innovation in the healthcare sector, making her a driving force in advancing precision medicine.
About the speaker:
Justin Barker, Senior Global Product Manager, Bio-Rad Laboratories
Justin Barker has been a life science industry professional for 20 years. He has worked to bring new innovations to market across reagents, consumables, instruments and software in various segments for multiple industry leading brands. Justin is currently the Senior Global Product Manager at Bio-Rad Laboratories for Research Use qPCR instruments and software.
Get Access to this Webinar
Share a little information with us to access this webinar.
Required fields